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Background: Microglia, the immune effector cells of the CNS and the signaling molecule Wnt, both play critical
roles in neurodevelopment and neurological disease. Here we describe the inducible release of exosomes from
primary cultured rat microglia following treatment with recombinant carrier-free Wnt3a.
Results: Wnt3a was internalised into microglia, being detectable in early endosomes, and secreted in exosomes
through a GSK3-independent mechanism. Electron microscopy demonstrated that exosomes were elliptical,
electron-dense (100 nm) vesicles that coalesced with time in vitro. In contrast to microglia, primary cortical neurons
released exosomes constitutively and the quantity of exosomes released was not altered by Wnt3a treatment. The
proteomic profile of the microglial-derived exosomes was characterised using liquid chromatography-tandem mass
spectrometry (LC/MS/MS) and the vesicles were found to be associated with proteins involved in cellular
architecture, metabolism, protein synthesis and protein degradation including β-actin, glyceraldehyde-3-phosphate
dehydrogenase, ribosomal subunits and ubiquitin (45 proteins in total). Unlike lipopolysaccharide, Wnt3a did not
induce a neurotoxic, pro-inflammatory phenotype in primary microglia.
Conclusion: These findings reveal a novel mechanism through which Wnt3a signals in microglia resulting in the
release of exosomes loaded with proteinaceous cargo.
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Microglia are the main immune effectors of the CNS
contributing to developmental processes and in the adult
to metabolite removal, trophic support through the se-
cretion of growth factors and to the clearance of toxic
factors and debris [1]. In response to injury or disease
microglia proliferate and transform into active ‘brain
macrophages’ to combat pathology and provide neuro-
protection [2]. However, in this chronically activated
state microglial-derived mediators can become detri-
mental to neuronal survival if the activating signal and
thus inflammatory mediator secretion persists.
Wnt proteins are a family of cysteine rich glycopro-
teins that play a role during development and in tumori-
genesis and have recently been implicated in the
pathogenesis of Alzheimer’s disease (AD); a chronic* Correspondence: claudie.1.hooper@kcl.ac.uk
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reproduction in any medium, provided the orneurodegenerative disease characterised by the presence
of neurofibrillary tangles and β-amyloid (Aβ) plaques
[3,4]. There are 19 human WNT genes, several of which
encode alternatively-spliced isoforms, which are emer-
ging to play diverse roles in the adult CNS [5,6]. There
are three main branches to the Wnt signaling system:
the β-catenin/GSK3 pathway, the planar cell polarity
pathway and the Wnt/Ca2+ pathway. Recently, it has
been shown that Wnt3a can induce β-catenin signaling
in N13-microglial-like cells [7]. In addition to these well
characterised Wnt signaling cascades there are other
Wnt pathways emerging including the Wnt-RAP1, Wnt-
PKA, Wnt-RYK, Wnt-aPKC, Wnt-GSK3 microtubule
signaling, WntROR2 and the Wnt-mTOR pathways
[8-10]. Wnt proteins initiate signaling through binding
Frizzled. Ten Frizzled isoforms (FZD 1-10) have been
identified in humans and mouse microglia have been
shown to express FZD 4, 5, 7 and 8 as well as the
Frizzled co-receptors LRP5/6 [11]. Signal specificity is
complex, but may be achieved through cell specificl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Proteomic profile of micriglial-derived exosomes induced by Wnt3a treatment
Protein MW (Da) Peptides matched Function
Laminin subunit beta-1 196776 1 Basement membrane
Clathrin heavychain 1 191477 9 Membrane trafficing
Laminin subunit gamma-1 177185 2 Basement membrane
Alpha-1-macroglobulin 167019 1 Inhibits proteases
Peroxidasin homolog 165029 16 ECM peroxidase (basement membrane)
Nidogen-1 136536 1 Basement membrane
Adipocyte enhancer-building protein 1 130847 4 Transcriptional repressor (cholesterol metabolism)
Major vault protein 95739 5 Drug resistance
Transitional endoplasmatic reticulum ATPase 89293 8 Budding of vesicels from ER
Integrin beta-2 84970 2 Cell adhesion
Heat shock protein HS 90-alpha 84762 1 Chaperone (folding of cyctolic proteins)
V-type proton ATPases catalytic subunit A 68283 1 Proton pump
Transketolase 67601 1 Cytosolic metabolic enzyme
Galectin-3-binding protein 63701 1 Cell adhesion via integrins
Dihydropyrimidinase-related protein 62157 1 CRMP (schizophrenia risk gene) development
ATP synthase subunit alpha, mitochondrial 59717 3 Mitochondrial enzyme
T-complex protein 1 subunit eta 59614 1 Chaperone (folding of cytosolic proteins)
Pyruvate kinase isozymes M1/M2 57781 7 Glycolysis (cytosol)
T-complex protein 1 subunit beta 57422 1 Chaperone (folding of cytosolic proteins)
Matrix metalloproteinase-19 57321 2 Secreted protease (ECMremodelling)
Cystosol aminopeptidase 56115 1 Protein turnover
Vitronectin 54271 1 Extracellular matrix
Lipoprotein lipase 53049 2 Lipid hydrolysis
Tubulin alpha-1B chain 50120 3 Structural
Tubulin beta-5 chain 49639 4 Structural
Actin, cytoplasmic 2 41766 28 Structural
Actin, cytoplasmic 1 41710 3 Structural
Protein Wnt-3a 39232 15 Treatment
Annexin A2 38654 2 Structural/ inhibits phospolipase A2 (anti inflam)/Apoptosis
Annexin A3 36341 9 Structural/ inhibits phospolipase A2 (anti inflam)/Apoptosis
Annexin A4 35826 2 Structural/ inhibits phospolipase A2 (anti inflam)/Apoptosis
Apolipoprotein E 35731 10 Lipoprotein



















Table 1 Proteomic profile of micriglial-derived exosomes induced by Wnt3a treatment (Continued)
Annexin A5 35722 1 Structural/ inhibits phospolipase A2 (anti inflam)/Apoptosis
40S ribosomal protein SA 32803 3 Protein synthesis
40S ribosomal protein SA 32803 1 Protein synthesis
40S ribosomal protein S3a 29926 1 Protein synthesis
Proteasome subunit beta type-7 29908 2 Proteasomal degradation
40S ribosomal protein S3 26657 5 Protein synthesis
Proteinsome subunit alpha type-2 25910 1 Proteasomal degradation
40S ribosomal protein S8 24190 2 Protein synthesis
40S ribosomal protein S5 22864 1 Protein synthesis
Ferritin heavy chain 21113 2 Intracellular iron storage
Ferritin light chain 1 20736 10 Intracellular iron storage
Ubiquitin 8560 1 Proteasomal degradation
Microglia (2500000 cells) were treated with Wnt3a (10 nM) for 8 hours in SFM. Cell culture medium was collected, centrifuged at 10000xg for 10 minutes, concentrated using 3kDa centrifugal devices and exosomes
were isolated at 100000xg. Exosomal proteins were separated by SDS-PAGE (10)% and visualised using coomassie blue. The exosomal proteome was subsequently interrogated using LC/MS/MS and database



















Figure 1 Coomassie stained gel of proteins isolated from
exosomal fractions derived from primary microglia. Primary
microglia (2500000 cells) were treated with or without Wnt3a
(10 nM) for 8 hours in SFM. Cell culture medium was collected,
centrifuged at 10000xg for 10 minutes, concentrated using 3kDa
centrifugal devices and exosomes were isolated at 100000xg.
Proteins were separated by SDS-PAGE and visualised using
coomassie blue.
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ero-oligomers with different affinities for Wnt ligands or
through the association of Frizzled with different combi-
nations of co-receptor [8-10,12].
A number of extracellular membrane-bound vesicles
have been identified to date including exosomes (which
form the focus of this study), microvesicles, membrane
particles and apoptotic blebs [13]. Extracellular vesicles
are present in a number of physiological fluids including
CSF [14], urine, amniotic fluid, saliva and blood [15].
Functions of extracellular vesicles are varied and include
inter-cellular communication through the transmission
of proteins, mRNA and miRNA, the removal of defective
or effete proteins, antigen presentation and the forma-
tion of morphogen gradients [16]. Extracellular vesicles
are also involved in the propagation of tumors as well as
viral and prion infections. Furthermore, Aβ is secreted
in exosomes, exosomal proteins accumulate in Aβ pla-
ques in AD [17] and insulin-degrading enzyme can act
to degrade Aβ inside exosomes [18]. Exosomes derived
from neuronal-like cells have also been found to contain
α-synuclein, a hallmark pathological feature of Parkin-
son’s disease, and application of such vesicles to neurons
confers cytotoxicity [19]. This suggests that exosomal
signaling might play important, but as yet incompletely
understood roles in the CNS.
Exosomes form within sorting endosomes giving rise
to multi-vesicular endosomes (or multivesicular bodies)
[20]. Multi-vesicular endosomes subsequently fuse with
the plasma membrane releasing exosomes or multi-
vesicular endosomes are directed to lysosomes for deg-
radation. Secretory vesicles might also form within other
organelles generating exosome-like vesicles.
In this study we sought to investigate the effects of
Wnt3a on the secretions from primary rat microglia
considering the important roles that microglia and Wnt
both play in development and in neurological disease.
Interestingly, we found that primary microglia secreted
exosomes following stimulation with Wnt3a. In contrast,
primary cortical neurons released such vesicles in a con-
stitutive manner. Microglial-derived exosomes were ap-
proximately 100 nm in diameter and contained a variety
of ontologically different proteins; some of which have
been reported to be present in exosomes derived from
other cell types.
Results
Proteomic analysis of exosomes secreted by Wnt3a
treated microglia
Tissue culture medium harvested from primary rat
microglia treated with carrier-free Wnt3a (10 nM) and
centrifuged at 100000xg contained proteins characteris-
tic of exosomes as demonstrated by proteomic profiling
(Table 1). Conversely, medium collected from controlmicroglia and centrifuged at 100000xg was completely
devoid of any detectable protein as shown by coomassie
staining of one dimensional SDS-PAGE gels (Figure 1).
The concentration of exosomal proteins present in the
extracellular fluid represents approximately 0.5% of total
cellular protein. The concentration of Wnt3a used (10
nM) caused a robust activation of TOPflash, a reporter
gene construct containing tandem repeats of optimal
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trol), indicating that the recombinant Wnt3a protein
was active and able to signal through the β-catenin/
GSK3 dependent pathway. Lot to lot variability in the
ability of Wnt3a to induce exosome secretion was not
observed as has been documented for other Wnt3a
induced signaling events [21]. Western blotting corrobo-
rated proteomic findings showing that the 100000xg
exosomal fraction contained Wnt3a and β-actin
(Figure 2A). Smaller vesicles were also isolated by a sub-
sequent centrifugation step at 200000xg. Western blot-
ting demonstrated the presence of Wnt3a, β-actin and
apoptosis-linked gene 2-interacting protein (Alix) in the
200000xg fraction (Figure 2A). In contrast, Alix was not
detectable in the 100000xg exosomal fraction 8 hours
post Wnt3a stimulation. However, 36 hours post Wnt3a
treatment Alix could be detected by western blotting in
the 100000xg fraction when the number of donor micro-
glia was increased 5 fold (Figure 2B).Figure 2 Representative western blots of proteins in exosomes
derived from Wnt3a treated microglia. Primary microglia
(2500000 cells per treatment) were treated with or without Wnt3a
(10 nM) for 8 hours in SFM (Control: ‘Con’ = without Wnt3a) (A). Cell
culture medium was collected, centrifuged at 10000xg for 10
minutes, concentrated using 3kDa centrifugal devices and exosomes
were isolated at 100000xg. Smaller membrane vesicles were
extracted at 200000xg for 16 hours. Proteins were separated by SDS-
PAGE and subjected to western blotting for Wnt3a, β-actin and Alix.
Primary microglia (12500000 cells per treatment) were treated with
or without Wnt3a (10 nM) for 36 hours in SFM (Control: ‘Con’ =
without Wnt3a) (B). Cell culture medium was collected, centrifuged
at 10000xg for 10 minutes, concentrated using 3kDa centrifugal
devices and exosomes were isolated at 100000xg. Proteins were
separated by SDS-PAGE and subjected to western blotting for Wnt3a
and Alix.Neither Wnt5a or Wnt5b (at concentrations of 10 -
500 nM) caused the release of lipid-bound vesicles from
microglia, 8 hours post treatment, as demonstrated by
two dimensional gel electrophoresis (2DGE) followed by
silver staining. Silver staining provides a more sensitive
method for the detection of protein than staining with
coomassie blue (Figure 3). Furthermore, other modula-
tors of GSK3 activity, used at physiologically relevant
concentrations, including lithium (5 mM), insulin (100
nM), DKK1 (30 nM), sonic hedgehog (500 nM) or reelin
(50 nM: active signaling fragment containing amino
acids 1221-2661) did not elicit exosome release or the
release of smaller lipid-bound vesicles from microglia
(data not shown).
Effects of Wnt3a on the inflammatory profile of microglia
Control microglia or microglia treated with Wnt3a for 8
(Figure 4A) or 24 hours (Figure 4B) did not secrete GM-
CSF, IFN-γ, IL1α, IL1β, IL2, IL4, IL6, IL10, IL12 or
TNFα. In contrast, LPS (10 ng/ml) treated microglia
secreted TNFα and IL1β, the archetypal pro-inflammatory
cytokines, at both of these time points. Wnt3a treated
microglia did not express inducible nitric oxide synthase
(iNOS) after 24 hours in culture as demonstrated by
Western blotting, whilst LPS (10 ng/ml) treated microglia
did express this enzyme (Figure 4C). Conditioned medium
collected from Wnt3a treated microglia did not possess
significant neurotoxic properties as demonstrated by
MTT and LDH assay (Figure 5). In contrast, conditioned
medium collected from LPS (10 ng/ml), oligomeric Aβ
(3 μM) or oligomeric α-synuclein (500 nM) treated
microglia was neurotoxic, which is consistent with pre-
viously published findings [22,23]. LPS and oligomeric
α-synuclein caused marginal, but non-significant,
neuronal death when added to cortical neuron cultures
with control microglial conditioned medium. The addition
of oligomeric Aβ in conjunction with control microglial
conditioned medium to neurons evoked significant albeit
comparatively low levels of death after 24 hours in culture.
Interestingly, conditioned medium collected from Wnt3a
treated microglia was slightly protective against neuronal
death induced by medium collected from microglia
treated with LPS (10 ng/ml), oligomeric Aβ (3 μM) or
oligomeric α-synuclein (500 nM), although the results
were not statistically significant. Collectively, these
findings suggest that Wnt3a treated microglia do not
exhibit a typical pro-inflammatory phenotype; in fact
they might confer a small level of neuro-protection.
Visualisation of microglial-derived exosomes induced by
Wnt3a treatment
Electron microscopy corroborated proteomic data and
demonstrated that Wnt3a (10 nM) treated microglia released
exosomes that were electron-dense and approximately
Figure 3 Wnt5a and Wnt5b fail to induce exosomes release
from microglia as demonstrated by 2DGE. Primary microglia
(2500000 cells) were either left untreated (Control) or treated with
Wnt3a (10 nM), Wnt5a (500 nM) or Wnt5b (500 nM) in SFM for 8
hours in SFM. Cell culture medium was collected, centrifuged at
10000xg for 10 minutes, concentrated using 3kDa centrifugal
devices and exosomes were then isolated at 100000xg. Proteins
were separated by 2DGE and visualised using silver staining.
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nm (Figure 6). Microglial-derived exosomes aggregated
in vitro and labelled positively with β-actin (Figure 6A)
and Wnt3a (Figure 6B), which illustrates their biological
nature. Freshly isolated exosomes were more disperse and
osmium tetroxide staining revealed an elliptical structure
enclosed by a lipid-bilayer (Figure 6C).
Double immuno-fluorescent staining in N9 microglial
cells demonstrated the presence of Wnt3a in early endo-
somes, 2 hours post treatment, with Wnt3a co-localising
with the endosomal marker Rab5. This indicates that
Wnt3a is endocytosed before being directed into exo-
somes for secretion (Figure 7). Single staining for Wnt3a
or Rab5 independently produced similar staining pat-
terns (data not shown).Wnt3a does not induce nuclear pyknosis or compromise
cell membrane integrity
Microglial cells treated with Wnt3a (10 nM) for 24
hours possessed large healthy nuclei, identical in appear-
ance and number to control cells, as demonstrated by
Hoechst 33342 staining (Figure 8A, B and C). Moreover,
exosomes do not contain the pro-apoptotic protein cyto-
chrome c as shown by LC/MS/MS (see Table 1). These
findings indicate that Wnt3a treatment does not trigger
apoptosis and thus it is inferred that membrane blebbing
is not elicited, which is a terminal event in the apoptotic
pathway. Therefore, apoptotic bodies most likely do not
account for the presence of the extracellular vesicles
identified in this study. Furthermore, fluoroscein diace-
tate staining revealed that microglial cultures treated
with Wnt3a (10 nM) for 24 hours comprised a similar
number of fluorescent cells as untreated control cultures
(Figure 8D, E and F). Fluoroscein diacetate is metabo-
lised and retained by healthy cells comprising an intact
plasma membrane resulting in the visualisation of an
intracellular green fluorescent product. This fluorescent
dye therefore provides a measure of cell membrane in-
tegrity. Thus, these results indicate that the microglial
cells are intact and cellular contents/organelles are
retained inside the microglial cells following exposure to
Wnt3a and most likely do not contaminate the exosomal
fraction.
Figure 4 Assessment of the inflammatory properties of Wnt3a in microglia. Microglia (1 million cells per treatment) were treated with
either Wnt3a (10 nM) or LPS (10 ng/ml) for 8 (A) or 24 hours (B) in SFM at 37°C. Control cultures were left in SFM for the corresponding time
points. Cell culture supernatants were then collected and analysed for the presence of cytokines using a 10-plex immuno-fluorescent assay.
Microglia (250000 cells per treatment) were treated with either Wnt3a (10 nM) or LPS (10 ng/ml) for 24 hours and then subjected to western
blotting for iNOS and β-actin (C). Control microglia were cultured in SFM for 24 hours. *** p < 0.001.
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Primary cultured rat cortical neurons released exosomes
constitutively and Wnt3a (10 nM) treatment did not
alter exosome secretion as measured in terms of total
exosomal protein and the observable banding patterns
visible upon coomassie staining (Figure 9A). As was the
case with microglia, Wnt3a was detectable in neuronal-
derived exosomes collected from Wnt3a (10 nM) treated
cortical neurons (Figure 9B). This suggests that Wnt3a
is endocytosed and packaged into exosomes sub-
cellularly as is the case with microglia. Exosomes derived
from cortical neurons also contained, Alix, the arche-
typal exosomal marker, as shown by western blotting
(Figure 9B).
Wnt3a does not bind non-specifically to the external
surface of exosomal membranes
To provide further evidence that Wnt3a traverses the
cell through the endocytic route and does not non-
specifically associate with the external surface of exoso-
mal membranes; exosomes were incubated with Wnt3a
in a cell free environment and the presence of Wnt in
the exosomal fraction was tested. Cortical neurons wereused to provide a source of exosomes due to the consti-
tutive nature of their release from this cell type.
Exosomes isolated from 2.5 million cortical neurons
were incubated with Wnt3a (10 nM) for 8 hours. The
exosomes were subsequently pelleted by centrifugation
at 100000xg and the exosomal fraction and the super-
natant were western blotted for the presence of Wnt3a
(Figure 10). Wnt3a was only present in the supernatant.
This suggests that Wnt3a does not attach non-
specifically to the external surface of the exosomal mem-
branes; a phenomenon that could potentially occur
through the hydrophobic lipid modifications that are
present on Wnt [24,25].
Wnt3a- induced exosome secretion from microglia is
independent of GSK3
The naturally occurring Wnt antagonist DKK1 (30 nM)
failed to inhibit Wnt3a-induced exosome release from
microglia (Figure 11A). The same concentration of
DKK1 (30 nM) caused the complete abatement of
Wnt3a-induced TOPflash activity in HEK293a cells
(Figure 11B). In fact, DKK1 potentiated Wnt3a-induced
exosome release as measured by the presence of β-actin
Figure 5 Assessment of the neurotoxic properties of Wnt3a
treated microglia. Primary microglia (300000 cells per treatment)
were treated with Wnt3a (10 nM), LPS (10 ng/ml), oligomeric Aβ
(3 μM) or oligomeric α-synuclein (500 nM) for 24 hours and the
medium was collected. Control medium was collected from
untreated microglia in SFM (SFM). This medium was then added
to cortical neuron cultures (500000 cells per treatment) for a
further 24 hours before neurotoxicity assays were performed.
Some neuronal cultures were exposed to conditioned medium
collected from microglia treated with LPS (10 ng/ml), oligomeric
Aβ (3 μM) or oligomeric α-synuclein (500 nM) in the presence of
medium collected from Wnt3a treated microglia (as indicated).
Neuronal death was assessed by MTT (grey bars) and LDH (black
bars) assays. In addition, LPS (10 ng/ml), oligomeric Aβ (3 μM) or
oligomeric α-synuclein (500 nM) were directly added to neuronal
cultures in the presence of conditioned medium collected from
control microglia to account for any direct neurotoxic effects of
the microglial activators and toxicity was assessed by LDH assay
(white bars: LDH control). * p < 0.05, ** p < 0.01.
Figure 6 Electron micrographs of exosomes derived from
primary microglia treated with Wnt3a. Microglia (2500000 cells)
were treated with Wnt3a (10 nM) for 8 hours in SFM. Cell culture
medium was collected, centrifuged at 10000xg for 10 minutes,
concentrated using 3kDa centrifugal devices and exosomes were
isolated at 100000xg. Exosomes were fixed then either negatively
stained with uranyl acetate (0.3%) in methyl cellulose (2%) following
immuno-gold staining with anti-β actin (A) or anti-Wnt3a (B) or
positively stained using 1% osmium tetraoxide (C). Exosomes were
visualised using a FEI Tecnai T12 BioTWIN transmission electron
microscope. A and B: colloidal gold represents 10 nm. C: scale bar
represents 100 nm.
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measure for total exosomal protein. In contrast, DKK1
had no effect on exosome secretion when incubated with
microglial cells alone. Inhibition of GSK3 using lithium
(5 μM), which mimics β-catenin/GSK3-dependent Wnt
signaling, did not evoke exosome release or accentuate
or attenuate Wnt3a-induced release (Figure 11A). Lith-
ium (5 μM) did however, activate TOPflash in HEK293a
cells to a similar degree as Wnt3a (Figure 11B). Together
these findings suggest that Wnt3a-induced exosome se-
cretion occurs independently of GSK3 in microglia.
Discussion
Research into exosomal signaling in the CNS is scant es-
pecially with regard to glial cells. However, astrocytes
and glioblastomas release exosomes containing mito-
chondrial DNA [26] and primary mouse microglia, BV2
microglial cells as well as the N9 microglial cell line
have been reported to secrete exosomes constitutively
[27-29]. We show here that primary rat microglia release
exosomes following stimulation with Wnt3a, but exo-
somes or indeed other proteins are not released under
control conditions in our study. This discrepancy withprevious findings might reflect the down-regulated na-
ture of our microglia isolated using percoll density gradi-
ent centrifugation compared to microglia isolated from
mixed glial cultures, or microglial cell lines, which display
Figure 7 Wnt3a co-localises with early endosomes intracellularly in microglia. N9 microglia. (50000 cells per treatment/coverslip on the day
of plating) were treated with Wnt3a (10 nM) for 2 hours then fixed and stained with rabbit anti-Wnt3a (1:500: green staining) and mouse anti-
Rab5 (1:500: red staining) (A). Nuclei were counterstained with Hoechst 33342. Scale bar represents 10 μm.
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(unpublished observations: J Pocock). Wnt3a-induced
exosomes were approximately 100 nm in diameter; typical
of exosomal size. The vesicles aggregated in vitro and
harboured immunoreactivity for Alix and β-actin and
contained a number of other structural enzymes as
demonstrated by LC/MS/MS. Wnt3a was found to be
associated with exosomes both by electron microscopy and
LC/MS/MS profiling. Furthermore, immuno-localisation
with Rab5 suggests that Wnt3a is internalised into early
endosomes before being released from the cell in
exosomes. This is consistent with a study that shows
that internalisation of Wnt is necessary for its signaling
[30]. The mechanism involved in Wnt3a-induced exo-
some secretion remains to be determined, although the in-
volvement of GSK3 was ruled out. Little is known about
the regulation of multi-vesicular body fusion and exosome
release, although calcium [31] and citron kinase (a RhoA
effector) [32] have been implicated. Interestingly, DKK1
potentiated Wnt3a-induced exosomes secretion, whilst
DKK1 challenge alone did not stimulate exosomes release.
This corroborates the notion that Wnt3a is acting to elicit
exosomes secretion through a pathway independent of
GSK3/β-catenin as blocking this pathway diverts Wnt3a
to augment the activation of an alternate route. This is
possible since DKK1 inhibits the GSK3/β-catenin pathway
not by preventing Wnt binding to Frizzled, but rather byblocking the interaction of Frizzled with the necessary
co-receptors, LRP5/6.
Wnt3a treated microglia did not secrete cytokines or
express iNOS and therefore by supposition the signaling
molecule nitric oxide was not released. Furthermore,
Wnt3a treated microglia did not possess neurotoxic
properties. In fact, Wnt3a treated microglia conferred
marginal protection against neuronal cell death elicited
by microglia treated with Aβ, α-synuclein or LPS. It has
recently been reported that Wnt3a increases the expres-
sion of IL-6, IL-12, and TNFα in microglia [11]. How-
ever, the control cultures in the study reporting this
were exposed to 1% BSA and it is not stipulated whether
the recombinant Wnt3a used was carrier-free. Carriers
could potentiate any microglial response especially if the
carrier is BSA [33,34]. In retinal cells activation of the β-
catenin/GSK3 dependent Wnt pathway with Wnt3a is
sufficient to induce inflammation characterised by vas-
cular endothelial growth factor (VEGF) and TNFα secre-
tion and the production of reactive oxygen species [35].
This suggests that Wnt signaling might act in a cell type
specific manner with respect to inflammatory signaling
depending on the receptor profile expressed on a par-
ticular population of cells.
Wnt3a associated with cortical neuron-derived exo-
somes following its prior addition to the extracellular
milieu. However, Wnt3a did not modify exosome
Figure 8 Wnt3a does not induce the formation of apoptotic nuclei in microglia or compromise cell membrane integrity. Apoptosis was
assessed using Hoechst 33342. Microglia on 13 mm coverslips (50000 cells per treatment) were treated with (A) and without (B) Wnt3a (10 nM)
for 24 hours then fixed in formaldehyde (4%) and incubated with Hoechst 33342 (17.8 μM). Apoptotic microglia were expressed as a percentage
of the total number of cells counted per field (C). Treatments were deemed statistically non-significant (NS) according to a two tailed student’s
T-Test. Cell membrane integrity was assessed using fluoroscein diacetate (FDA). Microglia on 13 mm coverslips (50000 cells per treatment)
were treated with (D) and without (E) Wnt3a (10 nM) for 24 hours then incubated with fluoroscein diacetate (35 μM: green staining) and Hoechst
33342 (17.8 μM: blue staining) to counter-stain cell nuclei. Fluoroscein diacetate positive cells were expressed as a percentage of the total number of
cells counted per field (F). Treatments were deemed statistically non-significant (NS) according to a two tailed student’s T-Test.
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tein levels in the 100000xg fraction and in the appearance of
observable bands apparent on coomassie-stained gels. How-
ever, for this to be verified absolutely further LC/MS/MS
analysis would have to be performed. Exosomes derived
from cortical neurons comprised a different protein profile
to microglial-derived exosomes as illustrated by coomassie
staining of the electrophoretically resolved exosomal pro-
teomes. Nonetheless, cortical neurons have been reported to
release exosomes containing β-tubulin, γ-actin, clathrin
heavy chain, ubiquitin and metabolic enzymes such as pyru-
vate kinase and glyceraldehyde 3 phosphate dehydrogenase
[36]; similar to those proteins found in the microglial derivedexosomes described in this study. This suggests that a num-
ber of common proteins are found in exosomes originating
from both cell types. In fact, the presence of metabolic
enzymes in exosomes appears to be characteristic of such
vesicles from a variety of cell types [37]. Heat shock proteins
and annexins are also found in exosomes from a number of
sources including keratinocytes and dendritic cells [38,39],
which is consistent with our findings. Endosomal-lysosomal
sorting proteins such as endosomal sorting complex
required for transport (ESCRT), tumour susceptibility gene
101 (Tsg-101) and Alix as well as tetraspanins are character-
istic of exosomes. However, not all exosomes express these
markers [37]. Alix was detectable in exosomes derived from
Figure 9 Coomassie stained gel of proteins isolated from
exosomal fractions derived from primary cortical neurons.
Primary cortical neurons (2500000 cells) were treated with or
without Wnt3a (10 nM) for 8 hours in SFM. Cell culture medium was
collected, centrifuged at 10000xg for 10 minutes, concentrated using
3kDa centrifugal devices and exosomes were isolated at 100000xg.
Proteins were separated by SDS-PAGE and visualised using
coomassie blue. Western blot of Wnt3a and Alix in exosomal
fractions derived from primary cortical neurons treated with and
without Wnt3a in SFM for 8 hours (B).
Figure 10 Assessment of non-specific binding of Wnt3a to
exosomal membranes. Exosomes were isolated from primary
cortical neurons (2500000 cells) and incubated with and without (±)
Wnt3a (10 nM) in a cell free environment (in SFM) for 8 hours.
Following the incubation the exosomes were pelleted by
centrifugation at 100000xg for 1 hour and the pellets and the
supernatants were subjected to western blotting for the detection
of Wnt3a and β-actin as an exosomal marker.
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vesicular fractions isolated fromWnt3a treated microglia.
The functional significance of Wnt3a induced exo-
some secretion from microglia remains to be deter-
mined. Neurons treated with exosomes derived from
Wnt3a treated microglia did not display an altered pro-
tein expression pattern as demonstrated by 2DGE (data
not shown). This implies that the exosomes do not sig-
nal to alter neuronal phenotype/function. However, the
effects of exosomal cargo transfer might be so subtle
that they are beyond the limits of detection by 2DGE.
Exosomes are known to play a role in antigen presenta-
tion [40], so it is conceivable that Wnt-3a-induced exo-
some production might play a role in the central
inflammatory response. Exosomes derived from Wnt3a
treated microglia might also serve to create morphogen
gradients during CNS development; certainly amoeboid
microglia play a key role in developmental processes. In
drosophila, Wingless (the fly homologue of mammalian
Wnts) is found in multi-vesicular bodies and large int-
racellular vesicles as well as export vesicles known as
argosomes [41,42]. Thus, Wingless/Wnt might be endo-
cytosed and then passed from cell to cell via exosome-
like vesicles to establish morphogen gradients. In
addition or alternatively, Wnt3a-induced microglial
derived exosomes might function as a clearance system
for unwanted cellular proteins. Our proteomic data
reveals the presence of ubiquitin and proteasomal subu-
nits in microglial derived exosomes suggestive of a de-
gradative role. Consistent with this, the tetraspanins,
CD82 and CD9, possessing tumour supressor properties,
down-regulate Wnt signaling through the exosomal dis-
charge of β-catenin [43]. Of note, Sonic hedgehog, an-
other modulator of GSK3 activity, when delivered using
small membrane derived vesicles has been shown to pro-
mote angiogenesis in vascular endothelial cells, which
Figure 11 Wnt3a-induced exosome secretion occurs
independently of GSK3 activity in microglia. Microglia were pre-
treated with DKK1 (30 nM) or lithium (5 μM) for 1 hour before the
addition of Wnt3a for 8 hours. Exosomes were subsequently
prepared by centrifugation of the cell culture medium at 10000xg
for 10 minutes, followed by concentration of the medium using
3kDa centrifugal devices before exosomes were isolated at
100000xg. The exosomal fractions were subjected to western
blotting for the detection of β-actin as a marker of exosomal
abundance (A). Lanes 3 and 4 depict: Wnt3a + inhibitor and the
effect of the inhibitor alone respectively. The TOPflash assay in
HEK293a cells illustrates the effects of Wnt3a, Wnt3a + DKK1, DKK1,
and lithium on β-catenin dependent signaling (B). ** p < 0.01.
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somes and other vesicular structures provide novel ave-
nues for future therapies.Conclusion
In summary, primary cultured rat microglia release elec-
tron dense exosomes after treatment with Wnt3a that
are loaded with proteinaceous cargo including structural
proteins, metabolic enzymes and proteins involved in
both protein synthesis and degradation. These findings
have implications for cellular cross-talk in the CNS, in-
volving bulk transfer of material, in both health and
disease.Methods
Materials
Sprague dawley rats were bred and reared in house from
stock animals obtained from Charles River UK Ltd
(Margate, Kent, UK). Human embryonic kidney 293a
cells (HEK293a; an adherent clone of HEK293 cells)
were purchased from Quantum Biotechnologies (Canada).
N9 microglial cells were a kind gift from Dr Paola
Ricciardi Castagnoli (CNR Cellular and Molecular
Pharmacology Centre, Milan, Italy). The TOPflash
firefly-luciferase reporter construct was purchased
from Millipore (Watford, UK). Fetal calf serum, Dulbeccos
Modified Eagle Medium (DMEM), Neurobasal medium,
B27 supplement and the rat cytokine 10-plex immuno-
fluorescent assay panels (LRC0002) were obtained from
Invitrogen (Paisley, UK). Papain digestion kits were from
Lorne Labs (Berkshire, UK). Recombinant carrier-free
mouse Wnt3a, Wnt5a, Wnt5b, dickkopf 1 (DKK1), reelin
and sonic hedgehog were from R&D Systems (Abingdon,
UK). α-synuclein was from Enzo Life Sciences (Exeter,
UK). β-amyloid (1-42) was from Dr David Teplow (UCLA,
California, USA). Recombinant insulin, percoll, lipopoly-
saccharide (LPS), Hoechst 33342, fluoroscein diacetate,
mouse anti-β actin and lithium were supplied by Sigma
(Dorset, UK). FuGENE6 was from Roche (Burgess Hill,
UK). Rabbit anti-Wnt3a and mouse anti-Alix were from
Cell Signaling Technology (Hertfordshire, UK). Mouse
anti-Rab5 was from Abcam (Cambridge, UK). Goat anti-
mouse IgG-HRP and goat anti-rabbit IgG-HRP were from
Autogen Bioclear (Wiltshire, UK). Anti-mouse and anti-
rabbit IgG conjugated to 10 nm colloidal gold was from
British Biocell (Cardiff UK). Enhanced chemiluminescence
reagents were from GE Healthcare (Buckinghamshire,
UK). C18 PepMap columns were from Dionex (Surrey,
UK). Amicon centrifugal devices (3kDa) were from Fisher
Scientific (Loughborough, UK). Immobiline Drystrips
(pH 3-11) were from GE Healthcare (Buckinghamshire,
UK). The ‘Cell Titre 96 AQueous One Solution Prolif-
eration Assay kit’ (MTT assay) and the CytoTox 96W
Non-Radioactive Cytotoxicity Assay kit (measures LDH’)
and Dual-Glo reagents were obtained from Promega
(Southampton, UK). Pioloform and EM grids come from
Agar Scientific (Stansted, UK).Aggregation of β-amyloid and α-synuclein
β-amyloid 1-42 (Aβ) peptide was resuspended in
1,1,1,3,3,3 hexafluoro-2-propanol (HFIP: 1 mM) and
homogenized using a Teflon plugged (250 μl) Hamilton
syringe. HFIP was removed by evaporation in a Speed-
Vac and Aβ was resuspended at a concentration of 5
mM in dimethylsulfoxide (DMSO) and sonicated for 10
minutes. For oligomer formation, Aβ (1-42) was diluted
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sodium dodecyl sulfate and incubated at 37°C for 24
hours then diluted to 100 μM with PBS and incubated at
37°C for 18 hours before use [45]. α-synuclein was
resuspended in PBS at a concentration of 68 μM and
incubated for 7 days at 37°C [22].
Primary microglial cell culture and treatment
Primary cultures of microglia were prepared from the
brains of P6 Sprague Dawley rats using percoll density
gradients as previously described [34]. In line with the
Animals Scientific Procedures Act (1986) UK, the animal
procedures undertaken to produce microglial cultures
fall under Schedule 1 and were approved by the local
ethics committee at the Institute of Psychiatry. All ani-
mals used in this study were treated in accordance with
standard guidelines for laboratory animal care. Microglia
were maintained at 37°C in a humidified atmosphere of
5% CO2 in air and were used after 1 day in vitro. Using
this approach microglial cultures were > 98% pure as
demonstrated by CD11b reactivity and morphological
criteria. Primary microglia were treated with Wnt3a (10
nM), or other agents as stipulated in the text, in serum
free medium (SFM) (Dulbeccos modified eagles medium:
DMEM) for 8 or 24 hours. Control cultures were incu-
bated in SFM for the corresponding period.
Culture and treatment of primary cortical neurons
Primary cortical neuronal cultures were prepared from
Sprague Dawley rat embryos on embryonic day 18 using
papain dissociation as previously described [46]. In line
with the Animals Scientific Procedures Act (1986) UK;
pregnant rats were killed by a Schedule 1 method prior
to the Schedule 1 killing of embryos. These animal pro-
cedures were approved by the local ethics committee at
the Institute of Psychiatry. Neurons were cultured in
neurobasal medium supplemented with B27 for 7 days
at 37°C in a humidified atmosphere of 5% CO2 in air.
Neuronal cultures were > 98% pure as demonstrated by
morphological criteria and staining for glial fibrillary
acidic protein (GFAP) and CD11b; markers of astrocytes
and microglia respectively. Following 7 days in vitro, pri-
mary neurons were treated with Wnt3a (10 nM) in neu-
robasal medium (minus supplements) for 8 hours.
Control cultures were incubated in neurobasal medium
(minus supplements) for the corresponding period.
Growth and maintenance of cell lines
N9 microglia and HEK293a cells were maintained in
DMEM supplemented with glutamine (2 mM), foetal bo-
vine serum (10%), penicillin (100 U/ml) and strepto-
mycin (100 μg/ml) in a humidified atmosphere of 5%
CO2 in air. N9 cells were plated on 13 mm glass cover-
slips (50000 cells/coverslip) and HEK293a cells wereplated in 48 well plates (40000 cells/well) the day before
use.
Luciferase TOPflash assays
HEK293a cells were transfected with TOPflash (400 ng)
using FuGENE6 (1 μl in a volume of 35 μl SFM). Wnt3a
(10 nM), DKK1 (30 nM), lithium (5 μM) or Wnt3a (10
nM) plus DKK1 (30 nM) were added to the culture
media 18 hours after transfection. After a further 6
hours at 37°C the medium was removed from the cells
and the firefly activity was measured using Dual-Glo
reagents in a Wallac Trilux 1450 Luminometer. Data for
each set of four replica transfections was averaged, the
control in each set normalized to 1 and data presented
as fold increases over control. All experiments were per-
formed in triplicate. To statistically compare treatments
a one-way analysis of variance (ANOVA) was used in
combination with a Tukey post-test. P values < 0.05 were
considered statistically significant.
Exosome preparation
Cell culture supernatant was typically harvested from 2.5
million cells (primary microglia or primary cortical neu-
rones), unless otherwise stated, after 8 hours in culture
and was centrifuged at 10000xg for 10 minutes to clear
large debris. The supernatant was then concentrated
using Amicon 3kDa centrifugal devices according to the
manufacturer’s instructions. The concentrated super-
natant was subjected to centrifugation at 100000xg for 1
hour to isolate exosomes. In some experiments a further
200000xg centrifugation step was performed for 16
hours to extract smaller vesicular particles.
Western blotting and coomassie gels
Cells, exosomes or other vesicular particles were har-
vested in lysis buffer (10 μl: 20 mM Tris-acetate, 1 mM
EDTA, 1 mM EGTA, 10 mM sodium β-glyceropho-
sphate, 1 mM sodium orthovanadate, 5% glycerol, 1%
Triton X-100, 0.27 M sucrose, 1 mM benzamidine, 4 μg/
ml leupeptin, 0.1% β-mercaptoethanol, pH 7.4) then
incubated on ice for 10 minutes. Protein concentrations
were determined according to the method of Bradford
and confirmed using a NanoDrop2000 at 280 nm.
Proteins (exosomal: 500 ng/well, cellular: 20 μg/well)
were resolved by SDS-PAGE (10%) then stained with
coomassie blue for 2 hours or transferred on to Immobi-
lon P-PVDF membranes for subsequent western blot-
ting. Membranes were probed according to standard
protocols. Briefly, membranes were incubated with ei-
ther mouse anti-β-actin (1:1000), rabbit anti-Wnt3a
(1:1000) or mouse anti-Alix (1:1000) for 2 hours at room
temperature. Membranes were then incubated for 2
hours at room temperature with goat anti-mouse IgG-
HRP (1:1000) or goat anti-rabbit IgG-HRP (1:1000).
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chemiluminescence reagents. In some instances to en-
sure equal protein loading membranes were reprobed
using mouse anti-β-actin (1:1000). Western blots were
performed in triplicate from 3 independent experiments;
therefore the blots shown are representative of a single
experiment.
Two dimensional gel electrophoresis
Exosomal proteins were isoelectro-focussed on immobi-
lized pH (3-11), dry, gradient strips using an Ettan IPG-
phor 3 system. Proteins were subsequently separated by
SDS-PAGE (10%) using an Ettan DALTtwelve large ver-
tical two-dimensional gel tank in running buffer (25 mM
Tris, 192 mM glycine, 0.1% SDS). Gels were fixed in
strong fix (40% ethanol, 10% glacial acetic acid) for 1
hour and then in weak fix (5% ethanol, 5% glacial acetic
acid) for 16 hours before proteins were visualized using
silver staining. Two-dimensional gels were performed in
triplicate from 3 independent experiments; therefore the
images shown are representative of a single experiment.
Liquid chromatography-tandem mass spectrometry (LC/
MS/MS)
Exosomal proteins were separated by SDS-PAGE (10%)
and visualised with coomassie blue. In-gel reduction, al-
kylation and digestion (with trypsin) was subsequently
performed. Peptides were extracted from the gel by a
series of acetonitrile and aqueous washes and lyophi-
lised. Each sample was then resuspended in ammonium
bicarbonate (50 mM) and analysed by LC/MS/MS.
Chromatographic separations were performed using an
Ultimate LC system (Dionex, UK). Peptides were
resolved by reversed phase chromatography on a 75 μm
C18 PepMap column using a three step linear gradient
of acetonitrile in formic acid (0.05%). The gradient was
delivered to elute the peptides at a flow rate of 200 nL/
minute over 60 minutes. The eluate was ionised by elec-
trospray ionisation using a Z-spray source fitted to a
QTof-micro operating under MassLynx v4.0. The instru-
ment was run in automated data-dependent switching
mode, selecting precursor ions based on their intensity
for sequencing by collision-induced fragmentation. The
MS/MS analyses were conducted using collision energy
profiles that were chosen based on the mass-to-charge
ratio (m/z) and the charge state of the peptide. Database
searching was carried out using MASCOT 2.2. All pep-
tide assignments were manually validated.
Assessment of cytokine secretion using a rat cytokine
10-plex immuno-fluorescent assay
Microglia (1 million cells per treatment) were treated
with either Wnt3a (10 nM) or LPS (10 ng/ml) for 8 or
24 hours in SFM at 37°C. Control cultures were left inSFM for the corresponding time points. Cell culture
supernatants were then collected and analysed simultan-
eously for the presence of cytokines (GM-CSF, IFN-γ,
IL1α. IL1β, IL2, IL4, IL6, IL10, IL12 and TNFα) accord-
ing to the manufacturer’s instructions and fluorescence
was quantified against standards using a Luminex200 in-
strument. All experiments were performed in triplicate.
To statistically compare treatments an ANOVA was
used in combination with a Tukey post-test. P values <
0.05 were considered statistically significant.
Cell titre 96 AQueous one solution proliferation assay
(MTT assay)
Primary microglia (300000 cells per treatment) were
treated with Wnt3a (10 nM), LPS (10 ng/ml), oligomeric
Aβ (3 μM) or oligomeric α-synuclein (500 nM) for 24
hours and the medium (SFM) was collected. Control
medium was collected from untreated microglia. This
medium was then added to cortical neuron cultures
(500000 cells per treatment) for a further 24 hours be-
fore the assay was performed. Some neuronal cultures
were exposed to conditioned medium collected from
microglia treated with LPS (10 ng/ml), Aβ (3 μM) or α-
synuclein (500 nM) in the presence of medium collected
from Wnt3a treated microglia. The assay principle is that
MTS [3-(4,5-dimethylthiazol-z-yl)-S-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl-2H-tetrazolium)], a tetrazolium
compound, is bioreduced by cellular NADP/NADPH to a
coloured formazan end-product, which is soluble in tissue
culture medium. Following treatment with conditioned
medium, neurons (in 250 μl of medium) were incubated
with the Cell Titre 96 AQueous One Solution reagent (50
μl), containing MTS, for 4 hours and the absorbance was
subsequently read at 492 nm using a 96-well Anthos HTll
microplate absorption photometer. Neurons were lysed
with triton- X100 (9% v/v) as a positive control (100%
death) and neuronal death was calculated as a percentage
of this total. All experiments were performed in triplicate.
To statistically compare treatments an ANOVA was used
in combination with a Tukey post-test. P values < 0.05
were considered statistically significant.
Cytotox 96® non-radioactive cytotoxicity assay kit (LDH
assay)
Cells were treated as described for the performance of the
MTT assay above. In addition, LPS (10 ng/ml), oligomeric
Aβ (3 μM) or oligomeric α-synuclein (500 nM) were dir-
ectly added to neuronal cultures in the presence of condi-
tioned medium collected from control microglia to
account for any direct neurotoxic effects of the microglial
activators. The assay measures lactate dehydrogenase
(LDH), a cytoplasmic enzyme, released from the cell upon
death. The assay is based on the formation of NADH from
NAD+ and lactate, which in turn reduces a tetrazolium
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brief, medium was collected from neurons (50 μl) and
added to assay substrate mix (50 μl) and incubated in that
dark for 30 minutes at room temperature. Subsequently,
stop solution (50 μl) was added and the absorbance was
read at 490nm. Neurons were lysed with triton- X100
(9% v/v) as a positive control (100% death) and neuronal
death was calculated as a percentage of this total. All
experiments were performed in triplicate. To statistically
compare treatments an ANOVA was used in combination
with a Tukey post-test. P values < 0.05 were considered
statistically significant.
Hoechst 33342 staining for nuclear morphology
Primary microglial cells (50000 cells per treatment) were
treated with and without Wnt3a (10 nM) for 24 hours.
Apoptosis was subsequently assessed using the fluores-
cent dye 20[epoxyphenyl]-5-[4-methyl-1-piperazinyl]-
2,50-bi-1H-benzimidazol (Hoechst 33342) [47]. Microglia
on 13 mm coverslips (50000 cell per treatment) were
fixed in formaldehyde (4%) in phosphate buffered saline
at 4°C, then incubated with Hoechst 33342 (17.8 μM)
for 10 minutes at 20°C. Immunofluorescence was visua-
lised and captured using a Zeiss Axioscope microscope
and nuclear morphology was appraised at 365 nm with
emission greater than 490 nm collected. Apoptotic cells
possess brightly stained pyknotic nuclei, whereas, non
apoptotic cells possess large weakly stained nuclei.
Apoptotic cells were counted on three coverslips per
treatment on three independent occasions (each cover-
slip comprised 10 fields of view). Apoptotic cells were
expressed as a percentage of the total number of cells
counted per field.
Fluoroscein diacetate staining for cell membrane integrity
Primary microglial cells (50000 cells per treatment) were
treated with and without Wnt3a (10 nM) for 24 hours.
Cell membrane integrity was subsequently assessed
using fluoroscein diacetate [47]. Primary microglial cells
on coverslips were incubated with fluoroscein diacetate
(35 μM) for 10 minutes at 37°C in the dark. Cell viability
was then assessed at 380 nm with emission greater than
505 nm collected. Fluoroscein diacetate is metabolised
in healthy cells to form a fluorescent product, which
emits at 530 nm, staining live cells green. Fluorescent
cells were counted on three coverslips per treatment on
three independent occasions (each coverslip comprised
10 fields of view) and cells were expressed as a percent-
age of the total number of cells counted per field.
Electron microscopy
Exosomes suspended in phosphate buffered saline (PBS:
10 μl) were fixed by the addition of 16% formaldehyde
(1 μl). The exosomal solution (3 μl) was then pipettedon to Pioloform coated electron microscopy grids. Ex-
cess fixative was quenched by exposing the grids to
quenching buffer (PBS, 50 mM glycine, 0.01% triton).
Non-specific binding was minimised by blocking the
grids in blocking buffer (PBS, 0.01% triton 0.1% acety-
lated BSA). The grids were then incubated with mouse
anti-β-actin (1:1000) or rabbit anti-Wnt3a (1:1000) for 1
hour at room temperature in blocking buffer and
washed in 6 changes of blocking buffer. The grids were
subsequently incubated with anti-mouse or anti-rabbit
IgG conjugated to 10 nm colloidal gold (1:100) for one
hour at room temperature before being washed with 4
changes of PBS. The exosomes were then fixed in glutar-
aldehyde (2%) and washed in 3 changes of distilled water
before being contrasted with a mixture consisting of 9
parts uranyl acetate (0.3%) to 1 part methyl cellulose
(2%). In other experiments, exosomes were fixed in glu-
taraldehye (2%) then washed in 3 changes of distilled
water before being stained with osmium tetroxide (1%).
Exosomes were visualised using a FEI Tecnai T12
BioTWIN transmission electron microscope fitted with
an AMT camera. Exosomes were stained in triplicate
from 3 independent experiments; therefore images are
representative of a single experiment.
Immunocytochemistry
N9 microglia (50000 cells per treatment/coverslip on the
day of plating) were treated with or without Wnt3a (10
nM) for 2 hours then fixed with methanol at 4°C for 5
minutes. Cells were washed in three changes of PBS and
then stained according to standard protocols. Briefly,
cells were incubated with rabbit anti-Wnt3a (1:500) and/
or mouse anti-Rab5 (1:500) before being incubated with
the appropriate fluorescent secondary antibody (1:500).
Nuclei were counter-stained with Hoescht 33342. Im-
munofluorescence was visualized and captured using a
Zeiss Axioscope microscope. All experiments were per-
formed in triplicate. Figures shown are representative of
a single experiment.
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